Company news
iSpecimen Inc. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
iSpecimen Expands Biospecimen Provider Network
February 7, 2023
iSpecimen Appoints Eric Langlois as Chief Revenue Officer
January 23, 2023
iSpecimen Names Tracy Curley as Chief Executive Officer
January 9, 2023
iSpecimen Appoints Joseph J. Basile to Board of Directors
December 4, 2022
iSpecimen Reports Third Quarter 2022 Financial and Operating Results
November 7, 2022
iSpecimen Launches New Open Feasibilities Dashboard on the iSpecimen Marketplace Platform to Enhance Biospecimen Fulfillment for Global Partner Network
October 26, 2022
iSpecimen to Report Third Quarter 2022 Results on November 8, 2022
October 24, 2022
iSpecimen Launches Marketplace Onsite Program to Optimize Biospecimen Procurement Process for Sample Providers
October 3, 2022
iSpecimen Names Chief Financial Officer, Tracy Curley, Interim CEO
September 21, 2022
iSpecimen Reports Second Quarter 2022 Financial and Operating Results
August 3, 2022
iSpecimen Adds New Global Biospecimen Suppliers to Proprietary Marketplace Platform for Researchers to Leverage
July 6, 2022
iSpecimen Appoints Evan Cox as Vice President of Product Management
June 7, 2022
iSpecimen Reports First Quarter 2022 Financial and Operating Results
May 9, 2022
iSpecimen to Report First Quarter 2022 Results on May 10, 2022
May 1, 2022
iSpecimen Unveils Enhanced iSpecimen Marketplace Platform to Help Scientists More Efficiently Find Desired Biospecimens for Research
April 25, 2022
iSpecimen Reports Full Year 2021 Financial Results
February 16, 2022
iSpecimen Expands Support of COVID-19 Research with Availability of Sequenced Specimens to Detect Variants
January 12, 2022
iSpecimen Expands Supplier Network of Human Biospecimens to Help Advance Research in Neurological Disorders
December 1, 2021
iSpecimen Inc. Announces Closing of Approximately $21 Million Private Placement
November 30, 2021
iSpecimen Inc. Announces $21 Million Private Placement
November 28, 2021
iSpecimen Reports Third Quarter 2021 Financial Results
November 3, 2021
iSpecimen to Participate in Upcoming Conferences in November 2021
October 31, 2021
iSpecimen Appoints Erik Uribe as Director of Global Implementations
October 25, 2021
iSpecimen® to Report Third Quarter 2021 Results on November 4, 2021
October 20, 2021
iSpecimen Expands Global Biospecimen Supplier Network and Access to Human Biospecimens Needed to Help Accelerate Development of Liquid Biopsies
October 6, 2021
iSpecimen Announces Inclusion in Russell Microcap® Index
September 13, 2021
iSpecimen Reports Second Quarter 2021 Financial Results
August 9, 2021
iSpecimen Launches Enhanced Custom Collection Service
July 28, 2021
iSpecimen Announces Closing of Over-Allotment Option in Connection with its Initial Public Offering
June 30, 2021
iSpecimen Announces Closing of Initial Public Offering
June 20, 2021
iSpecimen Announces Pricing of Initial Public Offering
June 15, 2021
Calls
The 5 newest of 11 calls. Every call is listed under its year.
- Ispecimen (NASDAQ:ISPC) Q2 2024 Earnings Call
Aug 6, 2024
Transcript - Ispecimen (NASDAQ:ISPC) Q1 2024 Earnings Call
May 7, 2024
Transcript - Ispecimen (NASDAQ:ISPC) Q4 2023 Earnings Call
Mar 14, 2024
Transcript - Ispecimen (NASDAQ:ISPC) Q3 2023 Earnings Call
Nov 2, 2023
Transcript - Ispecimen (NASDAQ:ISPC) Q2 2023 Earnings Call
Aug 2, 2023
Transcript
Decks
The 5 newest of 13 decks. Every deck is listed under its year.
- Investor Presentation (August 2024)
Investor deck · 28 slides · August 2024
- Investor Presentation (May 2024)
Investor deck · 31 slides · May 7, 2024
- Investor Presentation (March 2024)
Investor deck · 31 slides · Mar 14, 2024
- Investor Presentation (November 2023)
Investor deck · 32 slides · Nov 2, 2023
- Investor Presentation (August 2023)
Investor deck · 32 slides · Aug 2, 2023